Dr. Davids is an Associate Professor of Medicine at Harvard Medical School and Clinical Research Director in the Division of Lymphoma at Dana-Farber Cancer Institute, in Boston, Massachusetts. He also serves as the Leader of the Lymphoma Program for the Dana-Farber/Harvard Cancer Center. In addition to maintaining a busy clinical practice focused mainly on CLL, Dr. Davids leads numerous clinical trials of novel combination regimens for patients with CLL and lymphoma. He also runs an independent laboratory that utilizes functional precision medicine techniques to study patient samples, with a goal of predicting response to therapy and understanding resistance mechanisms to targeted therapies.